Sectra AB Class B (61L0) Price & Analysis

Compare

1 Followers

61L0 Stock Chart & Stats

€23.06

€0.30(1.31%)

At close: Jan 08 4:00 PM EST

€23.06

€0.30(1.31%)

Day’s Range― - ―

52-Week Range€16.01 - €33.52

Previous CloseN/A

Volume0.00

Average Volume (3M)5.00

Market Cap

€3.30B

Enterprise Value€35.30B

Total Cash (Recent Filing)€1.02B

Total Debt (Recent Filing)€95.09M

Price to Earnings (P/E)54.4

Beta0.63

Next Earnings

Mar 06, 2026

EPS Estimate

0.06

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.07

Shares Outstanding182,017,440

10 Day Avg. Volume0

30 Day Avg. Volume5

Financial Highlights & Ratios

PEG Ratio3.22

Price to Book (P/B)29.81

Price to Sales (P/S)17.64

P/FCF Ratio70.34

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Low Leverage And High ROEExtremely low leverage plus a 32.06% TTM ROE indicates a conservative capital structure and efficient use of equity. This durability supports continued R&D and contract execution, reduces refinancing risk, and provides financial flexibility through economic cycles.

Strong Profit Margins And Operational EfficiencyVery high gross margin and healthy EBIT/EBITDA show product-level pricing power and low direct cost intensity. Sustained margins provide cash to fund innovation and margins are a durable advantage in software-enabled medical imaging and cybersecurity.

Recurring Revenue ModelA business model built on software licensing, maintenance and long-term contracts creates predictable recurring revenue. This supports stable cash flows, aids customer retention, and makes revenue more resilient to one-time sales volatility over multi-quarter horizons.

Bears Say

Slowing Top-line GrowthRevenue growth has slowed to ~3% TTM, signaling deceleration in market traction or sales cadence. Over 2-6 months this can constrain reinvestment capacity and make it harder to expand market share without either higher sales intensity or new product wins.

Decline In Free Cash Flow GrowthAn 11.73% TTM drop in free cash flow growth suggests rising working capital needs or timing effects. Reduced FCF growth can limit funding for capex, acquisitions, or increased R&D, and makes sustaining investment programs and shareholder returns more challenging.

Concentration In Healthcare End MarketHeavy exposure to healthcare procurement and regulatory environments concentrates demand risk. Budget cycles, public-sector procurement delays, or reimbursement pressures can materially affect sales cadence and contract timing across multiple quarters.

Sectra AB Class B News

Sectra Reports Strong Growth and Profitability in H1 2025/2026

An update from Sectra AB Class B ( ($SE:SECT.B) ) is now available. Sectra reported significant growth in...

2M ago

Is 61L0 a Buy, Before Earnings?

Sectra AB Class B (61L0) is scheduled to report 2nd quarter earnings on 12/12/2025, before the market opens....

3M ago

Sectra AB Reports Strong Growth and Strategic Transition in Q1 2025/2026

An announcement from Sectra AB Class B ( ($SE:SECT.B) ) is now available. Sectra AB’s first quarter of...

6M ago

Sectra AB Announces 2025 Annual General Meeting

An announcement from Sectra AB Class B ( ($SE:SECT.B) ) is now available. Sectra AB has announced its...

7M ago

Sectra’s 2024/2025 Report: Advancing Healthcare and Cybersecurity

Sectra AB Class B ( ($SE:SECT.B) ) just unveiled an announcement. Sectra’s Annual and Sustainability Report for 2024/2025...

8M ago

Sectra AB Reports Solid Growth Amidst Business Model Transition

Sectra AB Class B ( ($SE:SECT.B) ) has issued an update. Sectra AB reported solid growth for the...

9M ago

61L1 Earnings Report this Week: Is It a Buy, Ahead of Earnings?

Sectra AB Class B (61L1) is scheduled to report 2nd quarter earnings on 12/12/2024, before the market opens....

1y ago

61L0 Earnings this Week: How Will it Perform?

Sectra AB Class B (61L0) is scheduled to report 1st quarter earnings on 09/05/2023, before the market opens....

2y ago

61L0 FAQ

What was Sectra AB Class B’s price range in the past 12 months?

Sectra AB Class B lowest stock price was €16.01 and its highest was €33.52 in the past 12 months.

What is Sectra AB Class B’s market cap?

Sectra AB Class B’s market cap is €3.30B.

When is Sectra AB Class B’s upcoming earnings report date?

Sectra AB Class B’s upcoming earnings report date is Mar 06, 2026 which is in 11 days.

How were Sectra AB Class B’s earnings last quarter?

Sectra AB Class B released its earnings results on Dec 12, 2025. The company reported €0.072 earnings per share for the quarter, beating the consensus estimate of €0.055 by €0.017.

Is Sectra AB Class B overvalued?

According to Wall Street analysts Sectra AB Class B’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Sectra AB Class B pay dividends?

Sectra AB Class B does not currently pay dividends.

What is Sectra AB Class B’s EPS estimate?

Sectra AB Class B’s EPS estimate is 0.06.

How many shares outstanding does Sectra AB Class B have?

Sectra AB Class B has 182,017,440 shares outstanding.

What happened to Sectra AB Class B’s price movement after its last earnings report?

Sectra AB Class B reported an EPS of €0.072 in its last earnings report, beating expectations of €0.055. Following the earnings report the stock price went down -3.072%.

Which hedge fund is a major shareholder of Sectra AB Class B?

Currently, no hedge funds are holding shares in DE:61L0

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Sectra AB Class B

Sectra AB (publ) provides solutions for medical IT and cybersecurity sectors in Sweden, the United Kingdom, the Netherlands, and rest of Europe. The company operates through Imaging IT Solutions, Secure Communications, and Business Innovation segments. The Imaging IT Solutions segment develops and sells medical IT systems and services for managing, archiving, and presenting various types of medical images and patient information, as well as for operational follow-up and radiation dose monitoring; maintenance services in the form of support and system monitoring; and consulting services related to integration, system design, data migration, and business development. The Secure Communications segment develops and sells products and services for secure voice and data communications, and protection of society's sensitive IT infrastructure; and project-based development, as well as offers security and threat analyses and system monitoring services for control systems in society's critical operations. The Business Innovation segment develops and sells IT systems for planning and monitoring orthopedic surgery; and products for medical education and research projects. It serves public and private healthcare providers comprising hospitals, and hospital and private clinic chains; and government agencies, defense departments, energy companies. Sectra AB (publ) was incorporated in 1957 and is headquartered in Linköping, Sweden.